UnitedHealth Group reported strong Q3 earnings with 12% revenue growth and solid cash flows. However, management provided cautious guidance for 2014, suggesting earnings may be flat due to Medicare Advantage funding pressures and other headwinds. This tempered outlook and focus on near-term challenges are likely to contribute to short-term negative sentiment among investors.

[-1]